Loading...
First Round of Abstract Submission Ends: Dec 31, 2026
Extended Early Bird Ends: Apr 28, 2026

Keynote Speakers

Prof. Alain R. Thierry
Université de Montpellier, France
Title: To be confirmed.
Will update soon.
Prof. Yannick J. Bomble
National Laboratory of the Rockies, USA
Title: Derisking cell free conversion platforms for the production of fuels and chemicals
Yannick Bomble, Ph.D. is a distinguished principal scientist and research group manager – NREL. Yannick joined the National Renewable Energy Laboratory in 2008. His team is multidisciplinary and has historically focused on the characterization/engineering of biomass degrading and metabolic enzymes to improve the production of biofuels and bioproducts in thermophiles. Lately, his research has focused more on enabling cell free biocatalysis wherein enzyme cascades operate in the absence of cellular constraints. His team is working on addressing the biggest challenges standing in the way of cost competitive production of fuels and bioproducts using this approach which he hopes will help derisk these technologies and further industrial adoption for biomanufacturing. He received his Ph.D. in Chemical Physics from the University of Texas at Austin (2006) and conducted his postdoctoral work in Computational Biology at the Scripps Research Institute in La Jolla, California (2007). Prior to this he obtained a B.S in Physics and Chemistry from the Universite de Lille (France) (2001) after two years of Mathématiques Superieures and Mathématiques Speciales at the Lycée Faidherbe in Lille (France).
Prof. Shiguo Chen
Zhejiang University, China
Title: To be confirmed.
Will update soon.
Dr. Abdulaziz Saud Fakhouri
College of Applied Medical Sciences, Saudi Arabia
Title: To be confirmed
Dr. Abdulaziz earned his bachelor’s degree from the Biomedical Technology Department at King Saud University (KSU), followed by his master’s and Ph.D. from the Biomedical Engineering Department at The Ohio State University. Currently, he is an Assistant Professor in the Biomedical Technology Department at the College of Applied Medical Sciences (CAMS) and the Deputy Director of Scientific Affairs at the Center of Excellence in Biotechnology Research at King Saud University (KSU). Also, he is an arbitrator of medical device qualifications for the Saudi Commission for Health Specialties. He previously worked as a Field Service Engineer for GE Healthcare. He also worked as the head of the Innovation Unit at CAMS, and later as the Vice Head of the Medical Technologies Innovation Unit at KSU. He also worked as a consultant for the Saudi Authority for Intellectual Property and for Yood Trading Company. He is also a certified trainer at Mawhiba for gifted students. Abdulaziz’s research interests focus on solving problems through innovative, patentable, and commercially viable biomedical products. Moreover, he is interested in innovation education, medical device design, 3D Bioprinting, biosensors development, cell and tissue engineering, and cancer research.
Prof. Martin von Bergen
Helmholtz-Centre for Environmental Research-UFZ GmbH, Germany
Title: Molecular and species-resolved analysis of metabolic interaction in the human intestinal microbiome
Will update soon.
Prof. Jingwei Xie
University of Nebraska Medical Center, USA
Title: Emerging Nanofiber Materials for Biomedical Applications
Will update soon.
Prof. Simon James Fong
University of Macau, Macau SAR
Title: To be confirmed.
Will update soon.
Dr. Hermann J. Heipieper
Helmholtz-Centre for Environmental Research-UFZ, Germany
Title: Strategies for Biotechnological Recycling and Upcycling of Plastics for a Circular Bioeconomy
Will update soon.
Prof. Nikola Kasabov
Auckland University of Technology, New Zealand
Title: To be confirmed.
Will update soon.
Dr. Rajinikanth Rajagopal
Sherbrooke Research and Development Centre, Canada
Title: Turning Agricultural Waste into Renewable Resources: Technologies Driving the Circular Bioeconomy
Dr. Rajinikanth Rajagopal is a Research Scientist at Agriculture and Agri-Food Canada (AAFC), Sherbrooke Research and Development Centre, where he leads innovative research programs in sustainable agriculture, waste valorization, and circular bioeconomy systems. His work focuses on transforming livestock and agri-food residues into renewable energy and value-added products, contributing to climate change mitigation and resource-efficient farming systems. He earned his Ph.D. in Environmental Engineering through a collaboration between the Indian Institute of Technology Roorkee and the Laboratory for Environmental Biotechnology at INRA, followed by postdoctoral research in France and Singapore. Dr. Rajagopal has authored over 100 peer-reviewed publications (H-index >31) and contributes actively to international research collaborations. He specializes in anaerobic digestion, nutrient recovery, and greenhouse gas mitigation, advancing practical solutions for sustainable and climate-resilient agricultural systems worldwide.
Prof. Zhen Yuan
University of Macau, Macau, China
Title: ROS Responsive Nanodrugs Alleviate Inflammation and Neuronal Apoptosis in Targeted Treatment of Traumatic Brain Injury
Dr. Zhen Yuan is a Professor with Faculty of Health Sciences at the University of Macau and concurrently serves as the Head of the Centre for Cognitive and Brain Sciences with the university. Professor Yuan has achieved a series of internationally recognized in the fields of brain neuroscience and biomedical optics. He has published over 400 high-quality SCI-indexed papers in top journals including Science Advances, Nature Communications, Cell Reports, Cell Reports Physical Sciences, Cell Biomaterials, Research, Microbiome, Translational Psychiatry, Biological Psychiatry, and Molecular Psychiatry, Advanced Materials, Small, Advanced Functional Materials, Nano Letters, Advanced Sciences, ACS Nano, Biomaterials, Nano Micro Letters, Angewandte Chemie International Edition, Theranostics, Optics Letters, and Applied Physics Letters. His Google Scholar H-index is 61, with a total citation of around 13000.
Professor Yuan currently serves on the editorial board of Quantitative Imaging in Medicine and Surgery and Journal of Innovative Optical Health Sciences, and is also a Senior Associate Editor for BMC Medical Imaging and Frontiers in Human Neuroscience. He is a Fellow of the Optical Society of America (OSA) and a Fellow of Vebleo. He holds positions as a Standing Committee Member of the Biomedical Optics Committee of the Chinese Optical Society, Vice President of the Macau Society of Nuclear Medicine and Molecular Imaging, a Council Member of the Chinese Society for Anatomical Sciences, and a Council Member of the Chinese Neuroscience Society. He has received the China's Top Optics Research Award, led 18 national and provincial-level projects, and has filed/been granted 10 international and domestic invention patents.
Prof. Shang-Ming Zhou
University of Plymouth, UK
Title: Advancing Bladder Cancer Screening with Electronic Health Records Through Advanced Machine Learning Techniques
Dr. Shang-Ming Zhou is a distinguished Professor in eHealth at the University of Plymouth, UK, where he serves as the Associate Head of School (Research), Chair of Operational Artificial Intelligence Group, and Deputy Director of the Centre for Health Technology in the Faculty of Health: Medicine, Dentistry and Human Sciences.

Dr. Zhou's work focuses on AI-driven personalized medicine, machine learning in health and care, health informatics, health data science, disease phenotyping, risk stratification, polypharmacy, multimorbidity, and public health research. His research on integrating information from multiple sources through advanced methods of type-1 and type-2 OWA operators has paved the way for data integration and aggregation under uncertain environments. He leads different projects, advancing healthcare data analytics for patient-centric innovations. He has also been awarded externally funded grants worth over £10 millions. Dr Zhou is the member of Editorial Board for 15 international journals.
Research Interests:

AI-driven personalized medicine, machine learning in health and care, health informatics, health data science, disease phenotyping, risk stratification, polypharmacy, multimorbidity, and public health research.